Theodore R. Schroeder is CEO at Nabriva Therapeutics plc (NBRV). They have made 4 open-market trades across 2 companies since 2009, most recently 2026-05-19.
CIK 0001378690
4 open-market purchases totalling $436K since 2011, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NBRV | BUY | 2021-12-28 | 2021-12-29 | $0.57 | $114K | +4.4% | -19.6% | -11.9% |
| NBRV | BUY | 2021-09-14 | 2021-09-15 | $1.13 | $113K | +14.5% | +7.3% | -43.3% |
| NBRV | BUY | 2019-08-27 | 2019-08-28 | $1.79 | $90K | +6.9% | -6.9% | -8.8% |
| CADX | BUY | 2011-05-17 | 2011-05-17 | $7.48 | $120K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2010-09-30 | 2010-10-04 | $8.35 | $418K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2010-06-30 | 2010-07-01 | $6.99 | $350K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2010-03-31 | 2010-04-01 | $9.18 | $459K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2009-12-31 | 2010-01-04 | $9.77 | $293K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2009-10-16 | 2009-10-19 | $10.72 | $214K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.